Expression of E-cadherin and catenins in invasive mammary carcinomas

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 561-567

  Zschiesche, Wolfgang ^a   Schönborn, Ines ^b   Behrens, Jürgen ^a   Herrenknecht, Kurt ^c   Hartveit, Flora ^d   Lilleng, Per ^d   Birchmeier, Walter ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c EISAI CO LTD   (Japan)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

Breast cancer; Catenins; E cadherin; Metastasis

Indexed keywords

ALPHA CATENIN; ANTIBODY; BETA CATENIN; CATENIN; PLAKOGLOBIN; UNCLASSIFIED DRUG; UVOMORULIN;

ACTIN FILAMENT; ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INVASION; CELL ADHESION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ALPHA CATENIN; AXILLA; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYTOSKELETAL PROTEINS; DESMOPLAKINS; FEMALE; GAMMA CATENIN; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTOR, ERBB-2; TRANS-ACTIVATORS;

EID: 1842301719     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Glukhova MA, Koteliansky V, Sastre X, and Thiery, J-P: Adhesive systems in normal breast and in invasive breast carcinoma. Am J Pathol 146: 1-11, 1995.
2. Geiger B, and Ginsberg D: The cytoplasmic domaine of adherens-type junctions. Cell Motil Cytosk 20: 1-6, 1991.
3. Geiger B, and Ayalon O: Cadherins. Annu Rev Cell Biol 8: 307-332, 1992.
4. 1, integrin. J Cell Sci 102: 437-446, 1992.
5. Takeichi, M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451 -1455, 1991.
6. Hulsken J, Behrens J, and Birchmeier W: Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr Opinions Cell Biol 6: 711-716, 1994.
7. Behrens J, Mareel MM, van Roy FM, and Birchmeier W: Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
8. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
9. Birchmeier W, and Behrens J: Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26, 1994.
10. Pierceall WE, Woodard AS, Morrow JS, Rimm DL, and Fearon ER: Frequent alterations in E-cadherin and α-and β-catenin expression in human breast cancer cell lines. Oncogene 11: 1319-1326, 1995.
11. Vleminckx K, Vakaet jr L, Mareel M, Fiers W, and Van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
12. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito S, Takeichi M, Matsuda H, and Hirohashi S: A truncated α-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54: 6282-6287, 1994.
13. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, and Isaacs WB: Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells. Correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 55: 4813-4817, 1995.
14. Moll R, Mitze M, Frixen UH, and Birchmeier W: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742, 1993.
15. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
16. Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S, and Hirohashi, S: Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Japan J Cancer Res 55: 266-273, 1994.
17. Takayama T, Shiozaki H, Inoue M, Tamura S, Oka H, Kadowaki T, Takatsuka Y, Nagafuchi A, Tsukita S, and Mori T: Expression of E-cadherin and α-catenin molecules in human breast cancer tissues and association with clinicopathological features. Int J Oncol 5: 775-780, 1994.
18. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, and Millis R: Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169; 245-250, 1993.
19. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara A, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, and Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastases. Cancer Res 53: 1696-1701, 1993.
20. Rimm DL, Sinard JH, and Morrow JS: Reduced α-catenin and E-cadherin expression in breast cancer. Lab Invest 72: 506-512, 1995.
21. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, and Syrjanen K: Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 174: 101-109, 1994.
22. WHO: Histological typing of breast tumors 2nd ed, WHO, Geneva, 1981.
23. Bloom HJG, and Richardson WW: Histological grading and prognosis of breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957.
24. Aberle H, Butz S, Stappert J, Weissig H, and Hoschnetzky H: Assembly of the cadherin complex in vitro with recombinant proteins. J Cell Sci 107: 3655-3663, 1994.
25. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, and Hofler, H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
26. Risinger JI, Berchuk A, Kohler MF, and Boyd J: Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genetics 7: 98-102, 1994.
27. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, and Hirohashi S: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
28. Oda T, Kanai Y, Shimoyama Y, Nagafuchi A, Tsukita S, and Hirohashi S: Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem Biophys Res Commun 193: 897-904, 1993.
29. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, and Isaacs WB: Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostata cancer cells. Cancer Res 53: 3585-3590, 1993.
30. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, and Niitsu Y: Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175-1181, 1995
31. Berx G, Cleton-Jansen AM, Nollet F, DeLeeuw WJF, Vandevijver MJ, Cornelisse C, and Van Roy F: E-cadherin is a tumor invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115, 1995.
32. Tabibzadeh S, Kong QF, Kapur S, Satyaswaroop PG, and Aktories K: Tumor necrosis factor-α-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/β-catenin and disassembly of actin filaments. Human Reprod 10: 994-1004, 1995.
33. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive ν-src gene. J Cell Biol 120: 757-766, 1993.
34. Hinck L, Nathke IS, Papkoff J, and Nelson WJ: β-Catenin: A common target for the regulation of cell adhesion by wnt-1 and src signaling pathways. Trends Biochem Sci 19: 5318-542, 1994.
35. Ochiai A, Akimoto S, Kanai Y, Shibata T, Oyama T, and Hirohashi S: C-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun 205: 73-78, 1994.
36. Kanai Y, Ochiai A, Shibata T, Oyama T, Ushijama S, Akimoto S, and Hirohashi S: C-erbB-2 gene product directly associates with β-catenin and plakoglobin. Biochem Biophys Res Commun 208: 1067-1072, 1995.
37. Daniel JM, and Reynolds AB: The tyrosine kinase substrate p120(cas) binds directly to E-cadherin but not to the adenomatous polyposis coli protein or α-catenin. Mol Cell Biol 15: 4819-4824, 1995.
38. Kinch MS, Clark GJ, and Burridge K: Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 130: 461-471, 1995.
39. Munemitsu S, Albert I, Souza B, Rubinfeld B, and Polakis P: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Scï USA 92: 3046-3050, 1995.
40. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, and Polakis P: Assoiation of the APC gene product with β-catenin. Science 262: 1731-1734, 1993.
41. Hülsken J, Birchmeier W, and Behrens J: E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J Cell Biol 727: 2061-2069, 1994.
42. Shibata T, Gotoh M, Ochiai A, and Hirohashi S: Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. Bioch Biophys Res Commun 203: 519-522, 1994.
43. Palacios J, Benito N, Pizarro A, Limeres MA, Suarez A, Cano A, and Gamallo C: Relationship between ERBB2 and E-cadherin expression in human breast cancer. Virchows Arch 427: 259-263, 1995.
44. McDonnell S, Wright JH, Gaire M, and Matrisian LM: Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes. Biochem Soc Transact 22: 58-63, 1994.
45. De Potter CR, and Quatacker J: The p185(erbB2) protein is localized on cell organelles involved in cell motility. Clin Exp Metastasis 11: 453-461, 1993.
46. Mansour EG, Ravdin PM, and Dressier L: Prognostic factors in early breast carcinoma. Cancer 74: 381-400, 1994.
47. Weinstat-Saslow D, and Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8: 401-407, 1994.
48. 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92: 7411-7415, 1995.